Rxivist logo

Author: David Cooper

  • Most recently observed institution: Pfizer

Rankings

  • All-time downloads: 270,499 (rank: 138 )
  • Categories:
    • infectious diseases: 173,349 (rank: 94 (tie) )
    • microbiology: 97,150 (rank: 137 (tie) )

Downloads per author, site-wide

Preprints

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 69,374 times
  • Download rankings, all-time:
    • Site-wide: 78
    • In infectious diseases: 29
  • Year to date:
    • Site-wide: 229
  • Since beginning of last month:
    • Site-wide: 255

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 66,567 times
  • Download rankings, all-time:
    • Site-wide: 85
    • In infectious diseases: 34
  • Year to date:
    • Site-wide: 98
  • Since beginning of last month:
    • Site-wide: 228

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera

microbiology more details view paper
  • Downloaded 57,003 times
  • Download rankings, all-time:
    • Site-wide: 101
    • In microbiology: 8
  • Year to date:
    • Site-wide: 11
  • Since beginning of last month:
    • Site-wide: 495

Neutralization of spike 69/70 deletion, E484K, and N501Y SARS-CoV-2 by BNT162b2 vaccine-elicited sera

microbiology more details view paper
  • Downloaded 40,147 times
  • Download rankings, all-time:
    • Site-wide: 156
    • In microbiology: 13
  • Year to date:
    • Site-wide: 24
  • Since beginning of last month:
    • Site-wide: 75

Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine

infectious diseases more details view paper
  • Downloaded 23,247 times
  • Download rankings, all-time:
    • Site-wide: 310
    • In infectious diseases: 114
  • Year to date:
    • Site-wide: 569
  • Since beginning of last month:
    • Site-wide: 1,089

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

infectious diseases more details view paper
  • Downloaded 14,161 times
  • Download rankings, all-time:
    • Site-wide: 546
    • In infectious diseases: 188
  • Year to date:
    • Site-wide: 135
  • Since beginning of last month:
    • Site-wide: 266

PanLingua

News